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Introduction
The need for a development strategy of any system, espe-
cially a system involving human and his health is imperative 
and it is out of discussion. One of the principles of the sys-
temic approach is the “strategic development”, which dem-
onstrates once again the need for elaboration of the develop-
ment strategy for pharmaceutical system in the Republic of 
Moldova.
Some motivational underlines regarding the need to de-
velop a strategy for pharmaceutical system in the Republic 
of Moldova were mentioned about 7 years ago – at the 6th 
Congress of Pharmacists [1].
It should be noted that National Health Politics [2] ad-
dresses only two aspects of the pharmaceutical system – 
“The implementation of computerized technology in the 
health domain will provide the centralized evidence of drugs 
on the market and will contribute to the security of phar-
maceutical products. The population will be guaranteed ac-
cess to essential and qualitative medicines”. It is obvious that 
these two issues do not cover all the problems facing today’s 
pharmaceutical system.
The development strategy of the health system for the 
period 2008-2017 [3], as well, does not provide the develop-
ment of pharmaceutical systems using systemic approach.
In this strategy, the drug and pharmaceutical activity do-
main is included in section 4 “Resource Management” and 
section 70 “The rational management of drugs”, which pro-
vide measures in two directions:
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Abstract
Background: To assess the actual pharmaceutical system in Moldova in order to show the strategic directions of the development of this system.
Material and methods: The methodology of the study is based on the systemic approach.  In order to highlight the issues of Pharmaceutical system that 
are needed to be reflected in the development strategy, it has been elaborated a special method of questionnaires for selected specialists of the highest 
level of professional competence as respondents.
Results: All respondents mentioned that having a development strategy for the pharmaceutical system is a real necessity. There were determined 
10 directions of the development strategy and the importance of each direction. Also, the respondents proposed additionally 21 directions and 21 another 
real problems to include in the strategy.
Conclusions: It has been highlighted the absence of the development strategy of the pharmaceutical system in the Republic of Moldova, which will bring 
to the light systematically full range of pending issues.  It has been developed a special method of questionnaires for selected specialists of the highest level 
of professional competence taking into consideration 3 factors: theoretical and practical training, seniority and experience of elaborating legislative and 
normative acts in the field of medicines and pharmaceutical activity.  There were argued five strategic directions of the development of pharmaceutical 
system in the Republic of Moldova, which include themselves about 50 issues, some more general, others – concrete, but all are towards achieving the 
overall goal – providing benefits to public and individual health.
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a) Ensure pharmaceutical safety;
b) Ensure accessibility to the drugs.
Ensuring the security of pharmaceutical system is ex-
pected to be achieved through series of concrete activities:
? the development and implementation of best practice 
rules – GLP, GCP, GMP, GDP, GPP;
? the improvement of computerized technology system 
in order to record the drugs circulation;
? the development of the mechanisms which will ensure 
the rational use of medicines.
In order to ensure accessibility to medicines there were 
provided the following activities:
? to reorganize the pharmaceutical departments in the 
Centers of  General Physicians (GP’s);
? to expand the compensated drugs assortment and the 
improvement of the mechanisms in order to ensure the 
population with these drugs;
? to improve the mechanism of price formation for drugs;
? to stimulate the development of domestic pharmaceu-
tical industry.
The mentioned strategic directions are still actual but the 
current situation of the pharmaceutical system is affected by 
the multitude of issues that need to be made as strategic ob-
jectives in a new term development program.
At the end of 2003 the Government approves national 
public health strategy for 2004-2020 [4], but in this strategy 
the words «drug» or «pharmaceutical» have not been found.
This strategy will not substitute any State Policy in the 
domain of Medicines [5], because this policy document 
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requires be reviewed and updated in accordance with the 
situation that it is created in the Moldovan pharmaceutical 
system [6].
The purpose of this document is to assess the actual phar-
maceutical system in Moldova which is oriented to argue the 
strategic directions of the development of this system.
Material and methods
With the purpose to assess the situation on strategic 
planning in the pharmaceutical system of Moldova there 
was started implementing of a special questionnaire in this 
regard.
Special interviewing is a method of sociological research 
in the process of which the respondents are experts selected 
on the principle of the highest level of professional compe-
tence.
In order to determine the competence of respondents, 
there was developed an algorithm, which includes three ba-
sic criteria:
I. Theoretical and practical competence (Ptp):
? having degree in pharmacy and work experience at 
least  for 2 years – 2 points;
? theoretical work (published scientific articles) and 
practical activities, the 1st or the 2nd professional cate-
gory – 5 points;
? PhD degree in pharmacy and practical activity, the 
highest professional category - 10 points;
? Work experience (Vm):
? Work experience up to 5 years – 2 points;
? Work experience >5 years to 10 years – 5 points;
? Work experience >10 years to 15 years – 8 points;
? Work experience over 15 years – 10 points;
II. Experience in elaborating of legislative and norma-
tive acts in the domain of medicines and pharmaceutical 
activity (Ean):
? Underlegislative acts/projects – 2 points;
? Underlegislative acts/projects and projects of Gov-
ernment decisions – 5 points;
? Underlegislative acts/projects and projects of Gov-
ernment decisions  and Orders – 8 points;
? Underlegislative acts/projects and projects of Gov-
ernment decisions, projects/orders and projects of 
politics documents – 10 points;
Using mentioned criterias in p. I-III there was elaborated 
the following algorithm:
ki= , in which(1)
ki – integrated coefficient characterizing the degree of re-
sponsibility of the respondent – the expert.
In order to validate the developed algorithm, there were 
determined the minimum and the maximum limits;
Minimum limit:    ki (min) =  = 0,2
      
(2)
Maximum limit:  
ki (max) = 
  
= 1,0 (3)
The acceptable limit: (ki(min) + ki(max)): 2 = 0,6.
Thus, in the questionnaires should be involved respon-
dents- experts possessing the degree of competence within 
0,6 – 1.0.
To collect the information on strategic planning in the 
pharmaceutical system there was developed a questionnaire 
(fig. 1).
All in total, 40 questionnaires there were printed and 
distributed, but there were collected only 36 or 90% of the 
required number.
Results and discussions
Characteristics of the respondents
In the process of questionnaires, there were involved 38 
pharmacists, the competence of which was illustrated by the 
integrated coefficient (ki), which was calculated using for-
mula (1). The results are presented in the table 1.
Table 1
Assessment of the respondents’ competence
Num-
ber of 
ques-
tion-
naire
Integrated 
coefficient 
of compe-
tence (ki)
Number 
of ques-
tionnaire
Integrated 
coefficient 
of compe-
tence (ki)
Number 
of ques-
tionnaire
Integra-
ted coeffi-
cient of 
compe-
tence (ki)
1 0,46 13 0,6 25 0,93
2 1,0 14 0,66 26 1,0
3 0,66 15 0,93 27 0,76
4 0,6 16 0,93 28 0,7
5  0,76 17 0,83 29 0,66
6 0,6 18 0,83 30 0,66
7 0,76 19 0,83 31 0,76
8 0,66 20 0,83 32 0,2
9 0,66 21 0,76 33 0,6
10 0,66 22 0,66 34 0,83
11 0,76 23 0,66 35 0,66
12 0,93 24 0,66 36 0,66
As in the process of questionnaires should be involved 
experts – respondents possessing a degree of competence 
within ³0,6-1.0 from the total of 36 questionnaires, two of 
questionnaires were excluded: questionnaire no. 1 (ki = 0.46) 
and questionnaire no. 32 (ki = 0.2). Thus, in the analysis of 
the information on strategic planning in the pharmaceuti-
cal system were included 34 questionnaires of pharmacists 
respondents.
According to domain of activity of the pharmacists re-
spondents, they work in different pharmaceutical fields: 
35.29% – Pharmacists, chiefs of pharmaceutical companies 
(12 respondents); 23.52% – Instructors of the pharmacists 
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Fig. 1.  Questionnaire Cassette 1.
Cassette 1
Questionnaire
Dear colleague, the absence in Moldova of a strategy for development of pharmaceutical system very often led to chaotic actions that keep 
this system in a «feverish» stage.
To redress the situation, please answer the questions of this questionnaire.
1. Do you consider it necessary to have a strategy for development of Moldova’s pharmaceutical system?
? Yes
? No
2. Motivate the negative answer (by tick);
? is it sufficient to have a strategic development of the health system;
? is it sufficient  the existence of State Policy in the domain of Medicine;
? the main components of the pharmaceutical system are private and they do not need „the state strategy”;
? other reasons (specify them): 
3. Motivate the positive answer (by tick);
? the strategy and strategic planning is the most effective way of selecting their aims, objectives and development programs;
? the strategy and the strategic plan is a real support for short - term planning and operational phase;
? the strategy of development of the health system does not contain 0,1 part of the strategic issues of the pharmaceutical system;
? other reasons (specify them): 
4. Set the rank (numbering taking into consideration the priority) for the next 10 points which are planned to be included in the stra-
tegy of development of the pharmaceutical system of RM (1-most important... 10 the least important)
? Improving the undergraduate and postgraduate training of pharmacists.
? The quality of pharmaceutical services provided in outpatient clinics and hospitals-based on ethic and professional principles.
? Authorization of pharmaceutical activity (licensing and accreditation).
? Pharmaceutical Assistance in rural areas.
? Ensuring patients with compensated drugs in outpatient departments.
? Improving the mechanism of price formation for drugs.
? Resumption and further development of medicines preparation.
? Improving the mechanisms of ethical promotion of medicines.
? Solving the situation regarding to informational ensuring of pharmaceutical act.
? Promoting the concept of good governance of the pharmaceutical system.
5. From your point of view, please mention additional development directions that deserve to be included in the strategy and deter-
mine their priority (points 1 to 10):
5.1. 
5.2. 
5.3. 
5.4. 
5.5. 
 6.  From your point of view, please mention at least five of the most important and concrete issues that should be included in the stra-
tegy of the development of the pharmaceutical system:
6.1. 
6.2. 
6.3. 
6.4. 
6.5. 
7. From your point of view, which would be the optimal period of the strategy of the development of the pharmaceutical system?
 ? 5 years;           ? 7 years;         ? 10 years;          ? 15 years;          ? 20 years.
8. Please specify some personal data (by tick):
a)  Domain of activity;
? Pharmacist, chief of a pharmaceutical company; ? Pharmacist practitioner of a pharmaceutical company;
? Training the pharmacists;   ? pharmaceutical research;
? coordination and control system;  ? others
b)  Work experience (tick):
? ? up to 5 years;     ?  >5-10 years;    ?  >10-15 years;     ?  >15 years;
c) Professional category that you hold at the moment (tick):
? ? 2nd;        ?  first ;        ?   the highest;
d) Scientific degree (tick):
 ? habilitated doctor in pharmaceutical science;      ? doctor in pharmaceutical science;        ? no scientific degree;
e)  Have you experience in elaborating of the project of documents (tick)
? sublegislative  ? yes          ? no
? government decisions ? yes          ?  no
? Orders                             ? yes         ? no
? politics                            ? yes          ? no
Thank you for your support!  _________________________ 
    (sign) - optional       
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(8 respondents); 23.52% – Pharmacist practitioners of phar-
maceutical companies (8 respondents); 11.76% – coordina-
tion and control system (4 respondents); 5.88% – pharma-
ceutical research (2 respondents);
According to work experience in the domain there were 
obtained the following data: 5 to 10 years – 5.88% (2 respon-
dents); > 10 to 15 years – 14.7% (5 respondents); > more 
than 15 years – 79.41%.
Regarding the professional category, most of the special-
ists have the highest category – 79.41%, the 1st category – 
14.7% and 5.88% have the 2nd category.
According to scientific degree the pharmacists are classi-
fied as follows: 17.64% are doctors in pharmaceutical scienc-
es and 2.94% – pharmacists with habilitated doctor in Phar-
maceutical Sciences, the rest of the respondents (79.41%) 
have no scientific degree.
Experience of elaborating normative legal acts possess 
12 respondents (35.29%), including trainers of pharmacists 
– 17.64%, specialists of coordination and control system – 
11.76% and pharmaceutical research – 5.88%.
Analysis of answers
When asked whether there is a need to create a strategy 
for the development of the pharmaceutical system in Mol-
dova all 34 pharmacists – respondents gave an affirmative 
answer. As a motivation for their positive response were 
ticked the following: 41.37% – mentioned p. a) – the strategy 
and strategic planning is the most effective way of selecting 
their aims, objectives and development programs; 31,03% – 
mentioned p.b) – the strategy and the strategic plan is a real 
support for short - term planning and operational phase; the 
last place 27,58% – ticked p.c) – the strategy of development 
of the health system does not contain 0,1 part of the strategic 
issues of the pharmaceutical system.
As a result of quantifying the strategic directions by es-
tablishing of the rank, it was determined the importance of 
each direction and it was highlighted the priority of the stra-
tegic directions in relation to the deadline needed to achieve 
the stipulated plan for the strategy (tab. 2).
All the experts added to the proposed directions in the 
4th question considered to indicate some other directions 
that might also be included in the strategy for the develop-
ment of the pharmaceutical system. Totally they proposed 
21 more directions, including: 5 more directions were pro-
posed by one expert; the other expert came with 4 more 
proposals; the other 5 experts came with 3 proposals; 13 
experts came with 2 proposals and 4 experts gave one pro-
posal each (tab. 3).
In conclusion, it was obtained that the first three strategic 
direction proposals were formulated by five experts; the fol-
lowing five proposals were submitted by four experts; next 
5 - by 3 experts, following six proposals were formulated by 
2 experts and the last two directions were formulated only 
by one expert. Thus, the degree of repeatability of other stra-
tegic directions which were proposed by the pharmacists-
experts is 90.5%.
To integrate the responses of the experts to question 5 
taking into consideration the directions formulated in ques-
tion 4, it was proposed to formulate question 6 – to men-
tion at least 5 of the most pressing and important issues that 
should be included in the strategy of the development of the 
pharmaceutical system. The answers to the 6th question are 
shown in table 4.
From the total number of respondents – experts, 32 of 
them mentioned 5 important issues, and 2 experts men-
tioned 4 issues each. Thus, all pharmacists-experts have 
mentioned 168 issues, which are oriented in two directions. 
The medium repeatability degree is 8, maximum – 16 and 
minimum – 2. From the total number of urgent issues, 3 of 
them were proposed by 16 respondents, 5 – by 14 respon-
dents, 12 – by 4 respondents and only one issue was pro-
posed by 2 experts.
On the 7th question (the optimal period for the strategy), 
Table 2
Ranking according to priorities of strategic directions of the development  
of the Republic of Moldova pharmaceutical system
Rank Strategic direction Accumulated amount
1 Authorization of pharmaceutical activity (licensing and accreditation) 103
2
The quality of pharmaceutical services provided in outpatient clinics and hospitals-based 
ethic and professional principles
105
3 Improving the mechanism of price formation for drugs 146
4 Pharmaceutical assistance in rural areas 156
5 Promoting the concept of good governance of the pharmaceutical system 164
6 Ensuring patients with compensated drugs in outpatient departments. 183
7 Improving the undergraduate and postgraduate training of pharmacists 197
8 Improving the mechanisms of ethical promotion of medicines 214
9 Resumption and further development of medicines preparation 220
10 Solving the situation regarding informational ensuring of pharmaceutical act 267
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the answers of the pharmacists-respondents were: 5years – 
11 (32.35%); 7 years – 4 (11.77%); 10 years – 17 (50%); 20 
years 2 (5.88%). The 15 year period was not mentioned by 
any expert. Thus, it is recommended the period of 10 years 
(2017-2027) for the strategy of the development of the phar-
maceutical system in Moldova. 
According to the survey, the data from the tables 2-4 
were grouped into the following five complex strategic di-
rections, in which are elucidated all the problems and issues:
I – Promoting an ethical pharmacy;
II – Strengthening the quality of the pharmaceutical ac-
tivity;
III – Ensuring of the accessibility to the medicines;
IV – Ensuring good conditions for the development of 
pharmaceuticals units;
V – Reviewing the pharmaceutical legislation by harmo-
nization with the EU acquis.
Table 3
Other directions that deserve to be included in the strategy according to the respondents’ opinion
Nr. d/r Proposed directions Nr. of the experts
1 Promoting of an ethical pharmacy 5
2 Rational use of medicines 5
3 Compliance with the regulation regarding expansion of the pharmacies 5
4 Licensing of the pharmaceutical activity by the Ministry of Health 4
5
Establishing a more drastic legislative regulating framework of the pharmaceutical activity and improving the 
legal framework
4
6 Extending the number of pharmacies with medicines preparation 4
7 Pharmacies should belong only to pharmacists 4
8 Excluding the commercial interest in pharmacies 4
9
To revise the regulations and standards that directly and indirectly affect the pharmaceutical system in the 
Republic of Moldova
3
10 Managing the pharmacies and pharmaceutical warehouses only by specialists with pharmaceutical education 3
11 The development and implementation of best practice rules (the ones that are not elaborated yet) 3
12
Strict compliance with occupied positions in the institutions according to education and skills of the pharma-
cists.
3
13 To restore the collaboration between the physician and pharmacist 3
14 More active promotion of healthy lifestyle oriented towards disease prevention 2
15
To create and promote the concept of the pharmacy ”model” by establishing advanced standards to all aspects 
of pharmaceutical activity
2
16 Reforming of the former central pharmacies into multifunctional units, including coordination and control. 2
17 Restoring a pharmacy chain with public capital 2
18 Taking over Romanian legislation in regulating pharmaceutical activity 2
19 Implementing informational system regarding patients files records 2
20
Improving the situation regarding human resources in pharmaceutical system (recording, migration, educati-
on recognition, equivalence of diplomas)
1
21
Creating database for pharmacists and their subsequent record, in order  to prevent practicing pharmaceutical 
activity by non-professional people
1
Table 4
The most pressing and important issues that should be included in the strategy 
of the development of the pharmaceutical system
Nr. d/r Most pressing and important issues Nr. of the experts
1 Licensing and accreditation 16
2 Compliance with regulation on pharmacies location 16
3 Taking concrete and effective measures that would not allow practicing pharmaceutical activity by non-spe-cialists 16
4 Perfecting pricing system for medicines 14
5 Preventing  the pharmaceutical warehouses from holding pharmacies (important factor in the exaggerated development of pharmaceutical chains) 14
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Nr. d/r Most pressing and important issues Nr. of the experts
6 Reorganizing of Pharmacists Association activity with an orientation to College of Pharmacists from Romania 14
7 Returning to actuality presence and functionality of automated information system of recording the move-ment of drugs 14
8 Approving the plan of the development of the pharmaceutical system 14
9 Pharmacists technician should not be allowed to dispense Rx products 4
10 Ensuring physical accessibility of medicines 4
11 Reviewing the right of existence of pharmacy chains 4
12 Orientation to recognized providers of medicines and exclusion of dubious suppliers 4
13 Liquidation of community pharmacy chains 4
14 Restoring the legislative framework regarding the statistics in the pharmaceutical domain 4
15 Proper hospitals supply with necessary qualitative and harmless medicines 4
16 Development of best practice rules 4
17 Correct prescribing the medicines by the doctors 4
18 Fight against abuse of drug advertising 4
19 Excluding the corruption in the process of centralized drug acquisitions 4
20 The development of domestic pharmaceutical industry 4
21 Changes / completing of the Administrative Code 2
Conclusions
1. It has been highlighted the absence of the strategy 
of the development of Moldovan pharmaceutical system, 
which would take care systemically of the full range of pen-
ding issues.
2. It has been developed a special method of question-
naires in which were involved specialists-experts with a 
quantified by three – factor degree of competence: theoreti-
cal and practical confidence, work experience and experi-
ence in elaborating of legislative and normative regulations 
in the domain of medicines and pharmaceutical activity.
3. There were highlighted five strategic directions for the 
development of Moldovan pharmaceutical system, which in-
clude about 50 issues, some of them are more general, others 
– are concrete, but all of them are oriented towards achieving 
a single goal – providing benefits to public and individual 
health.
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